Health
First human trial of AstraZeneca COVID-19 vaccine shows promise – Canada.com
LONDON — AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, with the stron…
LONDON — AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, with the strongest response seen in people who received two doses.
The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medica…
-
General21 hours agoVote counting begins for Townsville mayoral by-election
-
General24 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
Noosa News23 hours agoLGAQ motions become voice for community
-
Business13 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI